TRIATHLON PS X3 TIBIAL INSERT 5532-G-809-E

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a health professional,other report with the FDA on 2020-03-26 for TRIATHLON PS X3 TIBIAL INSERT 5532-G-809-E manufactured by Stryker Orthopaedics-mahwah.

Event Text Entries

[188212781] An event regarding infection involving a triathlon insert was reported. The event was not confirmed. Method & results: device evaluation and results: not performed as product was not returned. Clinician review: no medical records were received for review with a clinical consultant. Device history review: all devices were manufactured and accepted into final stock with no relevant reported discrepancies. Complaint history review: no other similar events were reported for the lot or sterile lot referenced. Conclusion: the exact cause of the event could not be determined because insufficient information was provided. Additional information including pathology reports, operative reports, progress notes, x- rays and return of the device are needed to fully investigate the event. Infection is a known possible adverse outcome of surgery, as noted in the instructions for use. All stryker products sold as sterile are validated to a minimum sterility assurance level (sal) of 10^-6 in accordance to applicable iso standards. When the sterile barrier of any device is opened, the sterility of that device becomes a function of handling and surgical technique and is beyond stryker? S control. Infection due to bacterial contamination, as supplied from the manufacturer, is an extremely rare event (see technical report 0000128012). If devices and / or additional information become available to indicate further evaluation is warranted, this record will be reopened. The following devices were also listed in this report: triathlon ps fem comp #8r-cem; cat# 5515f802; lot# aem4f, tri ts baseplate size 8; cat# 5521-b-800; lot# d4l3oa, triathlon asymmetric x3 patella; cat# 5551-g-401; lot# x685, simplex p - us full dose 10-pk; cat# 61911010; lot# rea068, simplex p - us full dose 10-pk; cat# 61911010; lot# rea068. It cannot be determined which, if any of these devices may have caused or contributed to the patient's experience.
Patient Sequence No: 1, Text Type: N, H10


[188212782] As reported: "patient's right knee was revised due to infection. This is the second revision of the patient's right knee. Revision 1 was a poly swap. All information the hospital has on the patient is attached to this email. " rep provided primary and revision usage sheets.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number0002249697-2020-00605
MDR Report Key9884115
Report SourceHEALTH PROFESSIONAL,OTHER
Date Received2020-03-26
Date of Report2020-03-26
Date of Event2020-02-27
Date Mfgr Received2020-02-27
Device Manufacturer Date2019-01-28
Date Added to Maude2020-03-26
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMR. COLLIN NEITZEL
Manufacturer Street325 CORPORATE DRIVE
Manufacturer CityMAHWAH NJ 07430
Manufacturer CountryUS
Manufacturer Postal07430
Manufacturer Phone2018315000
Manufacturer G1STRYKER ORTHOPAEDICS-MAHWAH
Manufacturer Street325 CORPORATE DRIVE
Manufacturer CityMAHWAH NJ 07430
Manufacturer CountryUS
Manufacturer Postal Code07430
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameTRIATHLON PS X3 TIBIAL INSERT
Generic NamePROSTHESIS, KNEE, PATELLO/FEMOROTIBIAL, SEMI-CONSTRAINED, UNCEMENTED, POROUS, C
Product CodeMBH
Date Received2020-03-26
Model Number5532-G-809-E
Catalog Number5532-G-809-E
Lot Number8248PD
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerSTRYKER ORTHOPAEDICS-MAHWAH
Manufacturer Address325 CORPORATE DRIVE MAHWAH NJ 07430 US 07430


Patients

Patient NumberTreatmentOutcomeDate
101. Hospitalization; 2. Required No Informationntervention 2020-03-26

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.